Pharming Group N.V. (PHAR)
NASDAQ: PHAR · IEX Real-Time Price · USD
8.09
+0.04 (0.50%)
At close: Jul 2, 2024, 3:57 PM
8.32
+0.23 (2.84%)
After-hours: Jul 2, 2024, 4:00 PM EDT
Pharming Group Employees
Pharming Group had 382 employees as of December 31, 2023. The number of employees increased by 50 or 15.06% compared to the previous year.
Employees
382
Change (1Y)
50
Growth (1Y)
15.06%
Revenue / Employee
$735,150
Profits / Employee
-$30,697
Market Cap
542.12M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 382 | 50 | 15.06% |
Dec 31, 2022 | 332 | 55 | 19.86% |
Dec 31, 2021 | 277 | 48 | 20.96% |
Dec 31, 2020 | 229 | 40 | 21.16% |
Dec 31, 2019 | 189 | 33 | 21.15% |
Dec 31, 2018 | 156 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
PHAR News
- 4 weeks ago - Pharming Group to participate in June investor conferences - GlobeNewsWire
- 4 weeks ago - Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union - GlobeNewsWire
- 6 weeks ago - Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders - GlobeNewsWire
- 6 weeks ago - Pharming Group to participate in May investor conference - GlobeNewsWire
- 7 weeks ago - Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025 - GlobeNewsWire
- 2 months ago - Pharming Group to report first quarter 2024 financial results on May 8 - GlobeNewsWire
- 2 months ago - Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards - GlobeNewsWire
- 2 months ago - Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025 - GlobeNewsWire